MLchartDataset catalogue

Bispecific antibody MDX447

Term · Oncology and biomedicine · MLC-T-ONC-012039

An antibody with potential antineoplastic activity. Specific for both the high-affinity immunoglobulin G (IgG) receptor CD64 and epidermal growth factor receptor (EGFR), bispecific antibody MDX447 may enhance cellular immune responses against EGFR positive cells, resulting in increased tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-012039
FieldOncology and biomedicine
SynonymsBsAb MDX447
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-012039",
  "term": "Bispecific antibody MDX447",
  "field": "Oncology and biomedicine",
  "definition": "An antibody with potential antineoplastic activity. Specific for both the high-affinity immunoglobulin G (IgG) receptor CD64 and epidermal growth factor receptor (EGFR), bispecific antibody MDX447 may enhance cellular immune responses against EGFR positive cells, resulting in increased tumor cell lysis.",
  "synonyms": [
    "BsAb MDX447"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bispecific-antibody-mdx447/"
}

Record 3,616 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.